news

Researchers Tout Cannabis as Therapeutic for Women’s Health

Researchers Tout Cannabis as Therapeutic for Women’s Health

While 38 percent of women worldwide suffer from chronic diseases, only 4 percent of research and development funding goes toward examining women’s health-care products and services. This leads women to seek out and experiment with alternative therapies, cannabis among them.

“The female reproductive system has the highest concentration of endocannabinoid receptors after the brain, making women particularly responsive to the medicinal properties of the plant.”

KANABÉ is Acquired by EFX LABORATORIES INC.

KANABÉ is Acquired by EFX LABORATORIES INC.

Kanabé is pleased to announce that it has been acquired by EFX Laboratories.

EFx is a privately held cannabis company whose defined business strategy is wellness through cannabis.  EFx is sponsoring a Health Canada submission of one of the first cannabis based Phase I & Phase III Clinical studies measuring cannabis as a viable post-operative treatment.  EFx also currently contract manufactures two piece medical cannabis pills for Broken Coast Cannabis Ltd (“BCC”) and Aphria Inc. (“Aphria”).

Kanabé Signs LOI with Abattis Bioceuticals

Kanabé Signs LOI with Abattis Bioceuticals

Kanabé signs LOI with Abattis to have them provide a full suite of downstream cannabis solutions for our premium health and wellness cannabis products.